Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D0Z1HQ
|
|||
| Former ID |
DNC001138
|
|||
| Drug Name |
PNU156804
|
|||
| Synonyms |
Hexylglutathione; 24425-56-7; UNII-M73SNN908F; S-Hexyl-L-glutathione; L-gamma-glutamyl-S-hexyl-L-cysteinylglycine; NSC 131114; CHEMBL345292; M73SNN908F; CHEBI:27704; Glycine, N-(N-L-gamma-glutamyl-S-hexyl-L-cysteinyl)-; C16H29N3O6S; 1ydk; AC1L3YPR; GTX; S-Hexyl-L-glutathione reduced; SCHEMBL1158164; CTK4F3647; HXJDWCWJDCOHDG-RYUDHWBXSA-N; 2c80; ZINC3874923; BDBM50095998; AKOS015893910; DB04132; LS-174055; Glycine, L-g-glutamyl-S-hexyl-L-cysteinyl-; FT-0770776; C02886; Glycine, L-.gamma.-glutamyl
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Renal transplantation [ICD-11: NE84; ICD-10: D89.8; ICD-9: 279.5] | Terminated | [1] | |
| Structure |
 |
Download2D MOL
|
||
| Formula |
C31H40ClN3O
|
|||
| Canonical SMILES |
CCCCCCCCCCCC1=CC=C(N1)C=C2C(=CC(=N2)C3=CC=CN3)OCC4=CC=CC=C4.Cl
|
|||
| InChI |
1S/C31H39N3O.ClH/c1-2-3-4-5-6-7-8-9-13-17-26-19-20-27(33-26)22-30-31(35-24-25-15-11-10-12-16-25)23-29(34-30)28-18-14-21-32-28;/h10-12,14-16,18-23,32-33H,2-9,13,17,24H2,1H3;1H/b30-22-;
|
|||
| InChIKey |
ODJQLZRYBXCIPR-VDFJEELKSA-N
|
|||
| PubChem Compound ID | ||||
| PubChem Substance ID |
5817, 585425, 819236, 821129, 823936, 824020, 824024, 826418, 829518, 829659, 830064, 834684, 835651, 836634, 6436227, 8022091, 8028121, 10229013, 10317448, 11538282, 17422866, 22394985, 24398011, 26703322, 26706156, 26736639, 44427844, 46393646, 46393976, 46488157, 50064611, 50130551, 53786802, 57336490, 57580714, 79069274, 85261598, 85261599, 85852805, 87226151, 87544252, 103398048, 103827809, 103993604, 104421164, 124361029, 128126732, 134340373, 134340524, 135052467
|
|||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Trusted, scientifically sound profiles of drug programs, clinical trials, safety reports, and company deals, written by scientists. Springer. 2015. Adis Insight (drug id 800008393) | |||
| REF 2 | Selective inhibitor of Janus tyrosine kinase 3, PNU156804, prolongs allograft survival and acts synergistically with cyclosporine but additively with rapamycin. Blood. 2002 Jan 15;99(2):680-9. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.